The RP-VITA Remote Presence Robot from iRobot has received a 510(k) clearance by the U.S. Food and Drug Administration (FDA) for use in hospitals. RP-VITA is the first autonomous navigation remote presence robot to receive FDA clearance.
RP-VITA is a joint effort between iRobot and InTouch Health. The robot combines autonomous navigation and mobility technologies developed by iRobot with telemedicine and electronic health record integration developed by InTouch Health.
The FDA clearance specifies that RP-VITA can be used for active patient monitoring in pre-operative, peri-operative and post-surgical settings, including cardiovascular, neurological, prenatal, psychological and critical care assessments and examinations.